定量超声分析检测的病变范围和严重程度对巨细胞动脉炎诊断和结局的影响
该研究基于TABUL研究和独立验证队列,开发结合彩色多普勒超声(CDS)定量模型与临床实验室模型的评分,用于预测巨细胞动脉炎(GCA)患者颞动脉活检(TAB)阳性的概率。CDS最佳模型包括颞动脉和腋动脉晕的最大内膜中层厚度及双侧性,临床模型包括炎症标志物升高、风湿性多肌痛、头痛和缺血症状。联合评分对TAB阳性的判别能力中等(AUC 0.77,95%CI 0.68-0.84),但对6个月临床结局无显著预测作用。
要点
- CDS定量评分联合临床特征可中等程度预测GCA患者TAB阳性,支持CDS作为替代TAB的工具。
- CDS最佳模型纳入颞动脉和腋动脉晕的最大内膜中层厚度及双侧性。
- 该评分对6个月临床结局无显著预测作用。
核心结论
- CDS定量分析与临床特征联合可用于识别TAB阳性的GCA患者,支持CDS作为替代TAB的替代工具。
- 未发现该评分对更差预后(6个月临床结局)有预测作用。
研究设计与样本
- 研究纳入TABUL研究中CDS阳性且确诊GCA的患者135例(女性68%,年龄73(8)岁)及独立验证队列72例(女性46%,年龄75(7)岁)。
- 拟合了4个CDS模型(包括颞动脉分支晕的数量和分布、颞动脉和腋动脉平均及最大内膜中层厚度等组合)和4个临床/实验室模型。
- 联合CDS与临床模型开发评分,用于预测TAB阳性的概率和6个月临床结局。
主要发现
- 预测TAB的最佳CDS模型使用颞动脉和腋动脉晕的最大内膜中层厚度尺寸及双侧性。
- 最佳临床模型包括炎症标志物升高、风湿性多肌痛(PMR)、头痛和缺血症状。
- 联合CDS和临床模型得出的评分预测TAB阳性的判别能力中等(AUC 0.77,95%CI:0.68,0.84)。
- 对6个月临床结局的预测未发现显著关联。
关键数值与推荐
- CDS最佳模型参数:颞动脉和腋动脉晕的最大内膜中层厚度尺寸及双侧性。
- 临床最佳模型参数:炎症标志物升高、PMR、头痛和缺血症状。
- 联合评分预测TAB阳性的AUC为0.77(95%CI:0.68,0.84)。
临床怎么用
- 对于CDS阳性的疑似GCA患者,可结合CDS定量参数(颞动脉和腋动脉晕的最大内膜中层厚度及双侧性)与临床特征(炎症标志物升高、PMR、头痛、缺血症状)计算TAB阳性概率。
- 该评分有助于识别可能从TAB中获益的患者,并支持在部分情况下使用CDS替代TAB。
- 该评分不应用于预测6个月临床结局。
局限性
- 研究仅纳入CDS阳性且确诊GCA的患者,可能存在选择偏倚。
- 验证队列样本量较小(72例)。
- 评分对6个月临床结局无预测作用,提示其预后价值有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop a quantitative score based on colour duplex sonography (CDS) to predict the diagnosis and outcome of GCA. METHODS: We selected patients with positive CDS and confirmed diagnosis of GCA recruited into the TA Biopsy (TAB) vs Ultrasound in Diagnosis of GCA (TABUL) study and in a validation, independent cohort. We fitted four CDS models including combinations of the following: number and distribution of halos at the TA branches, average and maximum intima-media thickness of TA and axillary arteries. We fitted four clinical/laboratory models. The combined CDS and clinical models were used to develop a score to predict risk of positive TAB and clinical outcome at 6 months. RESULTS: We included 135 GCA patients from TABUL (female: 68%, age 73 (8) years) and 72 patients from the independent cohort (female: 46%, age 75 (7) years). The best-fitting CDS model for TAB used maximum intima-media thickness size and bilaterality of TA and axillary arteries' halos. The best-fitting clinical model included raised inflammatory markers, PMR, headache and ischaemic symptoms. By combining CDS and clinical models we derived a score to compute the probability of a positive TAB. Model discrimination was fair (area under the receiver operating characteristic curve 0.77, 95% CI: 0.68, 0.84). No significant association was found for prediction of clinical outcome at 6 months. CONCLUSION: A quantitative analysis of CDS and clinical characteristics is useful to identify patients with a positive biopsy, supporting the use of CDS as a surrogate tool to replace TAB. No predictive role was found for worse prognosis.
引用
- Monti S, Ponte C, Pereira C, et al. The impact of disease extent and severity detected by quantitative ultrasound analysis in the diagnosis and outcome of giant cell arteritis. Rheumatology (Oxford). 2020. PMID: 31848610. doi:10.1093/rheumatology/kez554
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。